Palo Alto Investors LP Karyopharm Therapeutics Inc. Transaction History
Palo Alto Investors LP
- $856 Million
- Q1 2024
A detailed history of Palo Alto Investors LP transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 5,102,193 shares of KPTI stock, worth $4.44 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
5,102,193
Previous 5,102,193
-0.0%
Holding current value
$4.44 Million
Previous $4.39 Million
75.61%
% of portfolio
0.9%
Previous 0.4%
Shares
19 transactions
Others Institutions Holding KPTI
# of Institutions
120Shares Held
72.4MCall Options Held
476KPut Options Held
175K-
Black Rock Inc. New York, NY9.45MShares$8.22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.34MShares$7.25 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX8.3MShares$7.22 Million0.48% of portfolio
-
Eversept Partners, LP New York, NY5.02MShares$4.36 Million0.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.5MShares$3.05 Million0.01% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $69.4M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...